Peritoneal Cavity Cancer clinical trials at UCSF
1 research study open to eligible people
Peritoneal cavity cancer is a type of cancer that occurs in the area lining the stomach and intestines. UCSF is researching new treatments for patients with solid tumors using a drug called XMT-1660 in a clinical trial. This trial is open to individuals with various solid tumor cancers.
Showing trials for
XMT-1660 in Participants With Solid Tumors
open to eligible people ages 18 years and up
A Study of XMT-1660 in Solid Tumors
San Francisco, California and other locations
Our lead scientists for Peritoneal Cavity Cancer research studies include Laura Huppert.
Last updated: